Replies to post #33840 on Humanigen Inc (HGENQ)

[DonDonDonDon]

In my head I had that korea would recruit 20 pts, but I cannot find that info anymore. Do you have any source for the 50 pts ?

On July 22nd, South Korea announced a phase I lenzilumab safety trial of 20 patients. It wasn't part of the ACTIV-5 trial.

https://ih.advfn.com/stock-market/NASDAQ/humanigen-HGEN/stock-news/85648204/humanigen-s-partner-in-south-korea-receives-minis

On August 30th, it was announced that 50 patients in the ACTIV-5 would be enrolled in South Korea.

#lenzilumab BET-B study has been approved in South Korea just now.

50 out of 400 patients will be selected in Korea.$hgen $telcon $kpmtech #remdesivir vs #lenzilumab pic.twitter.com/HMVZpUvjAL

— gbe_estory (@EstoryGbe) August 30, 2021